TD Cowen Has Lowered Expectations for MetLife (NYSE:MET) Stock Price

MetLife (NYSE:METGet Free Report) had its price objective cut by TD Cowen from $91.00 to $88.00 in a research report issued on Wednesday,Benzinga reports. The brokerage currently has a “buy” rating on the financial services provider’s stock. TD Cowen’s price target indicates a potential upside of 28.07% from the stock’s current price.

Other analysts have also issued research reports about the stock. Wells Fargo & Company dropped their price target on shares of MetLife from $97.00 to $93.00 and set an “overweight” rating on the stock in a research report on Wednesday, February 25th. Mizuho set a $100.00 target price on MetLife in a research report on Thursday, February 12th. Morgan Stanley cut their price target on MetLife from $101.00 to $93.00 and set an “overweight” rating for the company in a research note on Tuesday, March 3rd. UBS Group increased their price target on MetLife from $94.00 to $98.00 and gave the stock a “buy” rating in a research report on Thursday, February 5th. Finally, Evercore set a $95.00 price objective on MetLife in a report on Tuesday, February 10th. Two equities research analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $93.67.

Read Our Latest Stock Report on MET

MetLife Trading Down 1.8%

Shares of NYSE:MET opened at $68.71 on Wednesday. The company has a current ratio of 0.20, a quick ratio of 0.20 and a debt-to-equity ratio of 0.52. MetLife has a 12-month low of $65.21 and a 12-month high of $85.00. The business has a 50 day moving average of $76.44 and a two-hundred day moving average of $78.46. The company has a market capitalization of $44.80 billion, a PE ratio of 14.62, a PEG ratio of 0.63 and a beta of 0.76.

MetLife (NYSE:METGet Free Report) last issued its quarterly earnings data on Wednesday, February 4th. The financial services provider reported $2.49 EPS for the quarter, topping analysts’ consensus estimates of $2.34 by $0.15. MetLife had a net margin of 4.38% and a return on equity of 21.81%. The business had revenue of $52.44 billion for the quarter, compared to analysts’ expectations of $31.43 billion. During the same quarter last year, the company earned $2.08 EPS. The business’s revenue was up 27.6% on a year-over-year basis. As a group, analysts forecast that MetLife will post 9.65 EPS for the current year.

Institutional Investors Weigh In On MetLife

Large investors have recently bought and sold shares of the company. Activest Wealth Management boosted its stake in shares of MetLife by 205.8% in the fourth quarter. Activest Wealth Management now owns 315 shares of the financial services provider’s stock worth $25,000 after acquiring an additional 212 shares during the last quarter. Vermillion & White Wealth Management Group LLC raised its stake in MetLife by 790.0% in the 3rd quarter. Vermillion & White Wealth Management Group LLC now owns 356 shares of the financial services provider’s stock valued at $29,000 after purchasing an additional 316 shares during the last quarter. Sound Income Strategies LLC lifted its holdings in MetLife by 58.9% in the 4th quarter. Sound Income Strategies LLC now owns 383 shares of the financial services provider’s stock valued at $29,000 after purchasing an additional 142 shares in the last quarter. Garton & Associates Financial Advisors LLC purchased a new position in MetLife in the 4th quarter valued at $30,000. Finally, Gunpowder Capital Management LLC dba Oliver Wealth Management acquired a new stake in MetLife during the 4th quarter worth $31,000. 94.99% of the stock is currently owned by hedge funds and other institutional investors.

MetLife Company Profile

(Get Free Report)

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.

Further Reading

Analyst Recommendations for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.